Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents

GENERIC NAME(S): Calaspargase Pegol-Mknl

OTHER NAME(S): Asparlas Solution

Uses

Uses

This medication is used to treat acute lymphoblastic leukemia (ALL). It works by starving tumor cells of certain needed nutrients, which slows or stops the growth of cancer cells.

This monograph is about the following calaspargase pegol product: calaspargase pegol-mknl.

How to use Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents

This medication is given by injection into a vein as directed by your doctor, usually once every 21 days. The injection is given by a health care professional, usually over 1 hour. The dosage is based on your body size and response to treatment.

Side Effects

Side Effects

Nausea, vomiting, diarrhea, or pain/swelling/redness at the injection site may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor right away if you have any serious side effects, including: severe stomach/abdominal pain, signs of an infection (such as sore throat that doesn't go away, fever, chills, cough), unusual bruising/bleeding (such as nose bleeds, black or bloody stools), signs of high blood sugar (such as increased thirst/urination), dark urine, yellowing eyes/skin.

Get medical help right away if you have any very serious side effects, including: shortness of breath/rapid breathing, chest/jaw/left arm pain, unusual sweating, confusion, sudden dizziness/fainting, pain/swelling/warmth in the arms or legs, sudden/severe headaches, trouble speaking, weakness on one side of the body, sudden vision changes.

A very serious allergic reaction to this drug can occur. Get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Precautions

Precautions

Before using calaspargase pegol-mknl, tell your doctor or pharmacist if you are allergic to it; or to pegaspargase; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: history of a serious reaction to L-asparaginase (such as bleeding, blood clots, pancreatitis), diabetes, bleeding/clotting problems, liver disease, pancreatitis.

Do not have immunizations/vaccinations without the consent of your doctor. Avoid contact with people who have recently received live vaccines (such as flu vaccine inhaled through the nose).

To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.

Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).

During pregnancy, this medication should be used only when clearly needed. It may harm an unborn baby. Women of childbearing age should have a pregnancy test before starting treatment with this medication. Ask about reliable forms of birth control while using this medication and for at least 3 months after stopping treatment. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication.

It is unknown if this drug passes into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this drug and for at least 3 months after stopping treatment. Consult your doctor before breast-feeding.

Interactions

Interactions

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.

Overdose

Overdose

If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.

Notes

Lab and/or medical tests (such as complete blood counts, blood clotting tests, liver function, amylase/lipase levels) should be done while you are using this medication. Keep all medical and lab appointments. Consult your doctor for more details.

Missed Dose

For the best possible benefit, it is important to receive each scheduled dose of this medication as directed. If you miss a dose, contact your doctor to establish a new dosing schedule.

Storage

Not applicable. This medication is given in a hospital or clinic and will not be stored at home.Information last revised October 2019. Copyright(c) 2019 First Databank, Inc.

Images

Sorry. No images are available for this medication.

Drug Survey

Are you taking Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents?

Are you considering switching to Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents?

How satisfied are you with the results?

VERY POOR
POOR
FAIR
GOOD
EXCELLENT

Are you planning to see a doctor about switching your medication?

How long have you been taking Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents?

Are you planning to see a doctor about switching your medication?

This survey is being conducted by the WebMD marketing sciences department.Read More

Thanks for taking our survey!

Recommended For You

Find a doctor near you

More Resources for Asparlas 750 Unit/Ml Intravenous Solution Asparaginase Enzyme Therapy Agents

Free Rx Coupon

Save up to 80% on your prescriptions.

Find More Drugs Used to Treat these Conditions

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.